299 related articles for article (PubMed ID: 23041840)
1. Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis.
de Rooy DP; Yeremenko NG; Wilson AG; Knevel R; Lindqvist E; Saxne T; Krabben A; Leijsma MK; Daha NA; Tsonaka S; Zhernakova A; Houwing-Duistermaat JJ; Huizinga TW; Toes RE; Baeten DL; Brouwer E; van der Helm-van Mil AH
Ann Rheum Dis; 2013 May; 72(5):769-75. PubMed ID: 23041840
[TBL] [Abstract][Full Text] [Related]
2. A genetic variant in granzyme B is associated with progression of joint destruction in rheumatoid arthritis.
Knevel R; Krabben A; Wilson AG; Brouwer E; Leijsma MK; Lindqvist E; de Rooy DP; Daha NA; van der Linden MP; Tsonaka S; Zhernakova A; Westra HJ; Franke L; Houwing-Duistermaat JJ; Toes RE; Huizinga TW; Saxne T; van der Helm-van Mil AH
Arthritis Rheum; 2013 Mar; 65(3):582-9. PubMed ID: 23440692
[TBL] [Abstract][Full Text] [Related]
3. Study of correlation of level of expression of Wnt signaling pathway inhibitors sclerostin and dickkopf-1 with disease activity and severity in rheumatoid arthritis patients.
Singh A; Gupta MK; Mishra SP
Drug Discov Ther; 2019; 13(1):22-27. PubMed ID: 30880318
[TBL] [Abstract][Full Text] [Related]
4. Association of genetic variants in the IL4 and IL4R genes with the severity of joint damage in rheumatoid arthritis: a study in seven cohorts.
Krabben A; Wilson AG; de Rooy DP; Zhernakova A; Brouwer E; Lindqvist E; Saxne T; Stoeken G; van Nies JA; Knevel R; Huizinga TW; Toes R; Gregersen PK; van der Helm-van Mil AH
Arthritis Rheum; 2013 Dec; 65(12):3051-7. PubMed ID: 23983153
[TBL] [Abstract][Full Text] [Related]
5. IL2RA is associated with persistence of rheumatoid arthritis.
van Steenbergen HW; van Nies JA; Ruyssen-Witrand A; Huizinga TW; Cantagrel A; Berenbaum F; van der Helm-van Mil AH
Arthritis Res Ther; 2015 Sep; 17(1):244. PubMed ID: 26350950
[TBL] [Abstract][Full Text] [Related]
6. Analysis of association of LRP5, LRP6, SOST, DKK1, and CTNNB1 genes with bone mineral density in a Slovenian population.
Mencej-Bedrac S; Prezelj J; Kocjan T; Komadina R; Marc J
Calcif Tissue Int; 2009 Dec; 85(6):501-6. PubMed ID: 19898734
[TBL] [Abstract][Full Text] [Related]
7. A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis.
Knevel R; de Rooy DP; Saxne T; Lindqvist E; Leijsma MK; Daha NA; Koeleman BP; Tsonaka R; Houwing-Duistermaat JJ; Schonkeren JJ; Toes RE; Huizinga TW; Brouwer E; Wilson AG; van der Helm-van Mil AH
Arthritis Res Ther; 2014 May; 16(3):R108. PubMed ID: 24886600
[TBL] [Abstract][Full Text] [Related]
8. LRP5 gene polymorphisms and radiographic joint damage in rheumatoid arthritis patients.
Bernardes M; Durães C; Oliveira A; Martins MJ; Lucas R; Costa L; Pereira JG; Ramos I; Machado JC; Simões-Ventura F
Osteoporos Int; 2018 Oct; 29(10):2355-2368. PubMed ID: 30019084
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in IL15 associate with progression of joint destruction in rheumatoid arthritis: a multicohort study.
Knevel R; Krabben A; Brouwer E; Posthumus MD; Wilson AG; Lindqvist E; Saxne T; de Rooy D; Daha N; van der Linden MP; Stoeken G; van Toorn L; Koeleman B; Tsonaka R; Zhernakoza A; Houwing-Duistermaat JJ; Toes R; Huizinga TW; van der Helm-van Mil A
Ann Rheum Dis; 2012 Oct; 71(10):1651-7. PubMed ID: 22440823
[TBL] [Abstract][Full Text] [Related]
10. Genetic contribution of DKK-1 polymorphisms to RA structural severity and DKK-1 level of expression.
Miceli-Richard C; Taylor KE; Nititham J; Seror R; Nocturne G; Boudaoud S; Dieude P; Constantin A; Devauchelle-Pensec V; Tobón GJ; Mariette X; Criswell LA
Ann Rheum Dis; 2015 Jul; 74(7):1480-1. PubMed ID: 25805736
[No Abstract] [Full Text] [Related]
11. Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort.
Seror R; Boudaoud S; Pavy S; Nocturne G; Schaeverbeke T; Saraux A; Chanson P; Gottenberg JE; Devauchelle-Pensec V; Tobón GJ; Mariette X; Miceli-Richard C
Sci Rep; 2016 Jan; 6():18421. PubMed ID: 26785768
[TBL] [Abstract][Full Text] [Related]
12. Sclerostin inhibition promotes TNF-dependent inflammatory joint destruction.
Wehmeyer C; Frank S; Beckmann D; Böttcher M; Cromme C; König U; Fennen M; Held A; Paruzel P; Hartmann C; Stratis A; Korb-Pap A; Kamradt T; Kramer I; van den Berg W; Kneissel M; Pap T; Dankbar B
Sci Transl Med; 2016 Mar; 8(330):330ra35. PubMed ID: 27089204
[TBL] [Abstract][Full Text] [Related]
13. Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover.
Gifre L; Ruiz-Gaspà S; Monegal A; Nomdedeu B; Filella X; Guañabens N; Peris P
Bone; 2013 Nov; 57(1):272-6. PubMed ID: 23981659
[TBL] [Abstract][Full Text] [Related]
14. Gene-gene interaction and association of Wnt/Β-catenin signalling pathway gene polymorphisms with ankylosing spondylitis susceptibility in the Chinese Han population.
Liu R; Zhang X; Jiang G; Ma Y; Yang J; Wu M; Han R; Chen M; Yuan Y; Hu X; Pan M; Xu S; Xu J; Shuai Z; Zou Y; Pan G; Pan F
Autoimmunity; 2019; 52(7-8):281-288. PubMed ID: 31656088
[No Abstract] [Full Text] [Related]
15. Genetic Factors for the Severity of ACPA-negative Rheumatoid Arthritis in 2 Cohorts of Early Disease: A Genome-wide Study.
de Rooy DP; Tsonaka R; Andersson ML; Forslind K; Zhernakova A; Frank-Bertoncelj M; de Kovel CG; Koeleman BP; van der Heijde DM; Huizinga TW; Toes RE; Houwing-Duistermaat JJ; Ospelt C; Svensson B; van der Helm-van Mil AH
J Rheumatol; 2015 Aug; 42(8):1383-91. PubMed ID: 26077402
[TBL] [Abstract][Full Text] [Related]
16. Variation at interleukin-6 receptor gene is associated to joint damage in rheumatoid arthritis.
Lopez-Lasanta M; Julià A; Maymó J; Fernández-Gutierrez B; Ureña-Garnica I; Blanco FJ; Cañete JD; Alperi-López M; Olivè A; Corominas H; Tornero J; Erra A; Almirall M; Palau N; Ortiz A; Avila G; Rodriguez-Rodriguez L; Alonso A; Tortosa R; Gonzalez-Alvaro I; Marsal S
Arthritis Res Ther; 2015 Sep; 17(1):242. PubMed ID: 26336855
[TBL] [Abstract][Full Text] [Related]
17. Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis.
Boman A; Kokkonen H; Ärlestig L; Berglin E; Rantapää-Dahlqvist S
Clin Rheumatol; 2017 May; 36(5):1005-1012. PubMed ID: 28190118
[TBL] [Abstract][Full Text] [Related]
18. PTGER4 gene variant rs76523431 is a candidate risk factor for radiological joint damage in rheumatoid arthritis patients: a genetic study of six cohorts.
Rodriguez-Rodriguez L; Ivorra-Cortes J; Carmona FD; Martín J; Balsa A; van Steenbergen HW; van der Helm-van Mil AH; González-Álvaro I; Fernandez-Gutiérrez B
Arthritis Res Ther; 2015 Nov; 17():306. PubMed ID: 26538147
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with serum soluble inhibitors of Wnt-β-catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis.
Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Ooboshi H; Kitazono T
Nephrology (Carlton); 2015 Sep; 20(9):639-45. PubMed ID: 25974190
[TBL] [Abstract][Full Text] [Related]
20. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
